NCT02362581已完成不适用
Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Number of admission days
研究概览
简要总结
Comparison of prophylaxis and on-demand treatment in children with moderate to severe hemophilia A.
This study determines to compare the efficacy of prophylaxis and on-demand treatment in moderate to severe hemophilia A children in King Chulalongkorn Memorial Hospital, Bangkok, Thailand
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Months 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age between 6 months to 18 years
- •Diagnosis severe and moderate hemophilia A
排除标准
- •platelet < 100,000/mm3
- •No factor VIII inhibitor
结局指标
主要结局
Number of admission days
时间窗: one year
Number of bleeding episodes require treatment
时间窗: one year
number of school days lost
时间窗: one year
次要结局
- Joint scores(one year)
- Quality of life score(one year)
- Amount of Facter VIII concentration used(one year)
研究者
Darintr Sosothikul
Pediatric Hematology/Oncology department
Chulalongkorn University
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric PatientsHemophilia ANCT02727647Chulalongkorn University16
Unknown
不适用
Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in TaiwanHemophiliaNCT02908243Taiwan Society of Thrombosis and Hemostasis350
招募中
1 期
ASC618 Gene Therapy in Hemophilia A PatientsHemophilia ANCT04676048ASC Therapeutics12
尚未招募
不适用
Stop study.haemophilia, prophylaxis, adherence, bleeds, arthropathy.hemofilie, profylaxe, therapietrouw, bloedingen, arthropathie.NL-OMON25201niversity Medical Center Utrecht (UMC Utrecht)90
已完成
不适用
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory CoastHemophilia ANCT05279924Cliniques universitaires Saint-Luc- Université Catholique de Louvain33
